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Initial stroke severity defined by the National Institutes of Health Stroke Scale (NIHSS) on admission was
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Abstract
Background: An incomplete circle of Willis (CoW) has been associated with a higher risk 
of stroke and might affect collateral flow in large vessel occlusion (LVO) stroke. We aimed 
to investigate the distribution of CoW variants in a LVO stroke and transient ischemic at-
tack (TIA) cohort and analyze their impact on 3- month functional outcome.
Methods: CoW anatomy was assessed with time- of- flight magnetic resonance angiog-
raphy (TOF- MRA) in 193 stroke patients with acute middle cerebral artery (MCA)- M1- 
occlusion receiving endovascular treatment (EVT) and 73 TIA patients without LVO. The 
main CoW variants were categorized into four vascular models of presumed collateral 
flow via the CoW.
Results: 82.4% (n = 159) of stroke and 72.6% (n = 53) of TIA patients had an incomplete 
CoW. Most variants affected the posterior circulation (stroke: 77.2%, n = 149; TIA: 58.9%, 
n = 43; p = 0.004). Initial stroke severity defined by the National Institutes of Health 
Stroke Scale (NIHSS) on admission was similar for patients with and without CoW vari-
ants. CoW integrity did not differ between groups with favorable (modified Rankin Scale 
[mRS]): 0– 2) and unfavorable (mRS: 3– 6) 3- month outcome. However, we found trends 
towards a higher mortality in patients with any type of CoW variant (p = 0.08) and a 
higher frequency of incomplete CoW among patients dying within 3 months after stroke 
onset (p = 0.119). In a logistic regression analysis adjusted for the potential confounders 
age, sex and atrial fibrillation, neither the vascular models nor anterior or posterior vari-
ants were independently associated with outcome.
Conclusion: Our data provide no evidence for an association of CoW variants with clinical 
outcome in LVO stroke patients receiving EVT.
K E Y W O R D S
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INTRODUC TION
The circle of Willis (CoW) is a polygonal arterial anastomotic system 
located at the skull base connecting the anterior with the posterior 
circulation as well as both cerebral hemispheres, thereby ensuring the 
maintenance of cerebral blood flow (CBF) [1,2]. Anatomical variants 
of the CoW are frequent with reported occurrence greater than 50% 
in the healthy population [2,3]. Most variants affect the posterior 
circulation with an average of 40% and more [1,3,4]. In patients with 
an intact CoW and gradual progression of occlusive atherosclerotic 
cerebrovascular disease, collateral flow via the CoW is provided via 
the communicating anterior (Acom) and posterior arteries (Pcom) [2]. 
However, CoW variants may affect the risk of stroke as well as the col-
lateral flow via the CoW during stroke. A study from van Seeters et al. 
[4] found that in healthy individuals with atherosclerotic disease but 
no prior vascular events, an incomplete anterior CoW was associated 
with an increased risk of future anterior circulation stroke with the 
highest risk in those with combined incomplete posterior and anterior 
circulation, whereas a posterior circulation variant alone was not. Due 
to the anastomotic system of an intact CoW, an acute intracranial ves-
sel occlusion might be at least partially compensated by collateral flow 
via the CoW, but less tolerated within an incomplete CoW. However, 
so far, there have been no studies analyzing the impact of ipsilateral 
and contralateral CoW variants on outcome in patients with middle 
cerebral artery (MCA)- M1- occlusion stroke.
In our study, we aimed to assess the frequency and distribution 
of CoW variants in a LVO stroke and transient ischemic attack (TIA) 
cohort and to evaluate the role of CoW variants for clinical out-
come in stroke. Therefore, we analyzed a large homogenous cohort 
of ischemic stroke patients with MCA- M1- occlusion, all subjected 
to mechanical thrombectomy within 6 h of symptom onset, and 
categorized them into groups with any, anterior or posterior CoW 
variants and according to vascular models of presumed collateral 
flow via the CoW (see Methods section). Demographic and clinical 
parameters such as stroke severity, etiology and 3- month modified 
Rankin Scale (mRS) were compared between groups. Furthermore, 
we assessed the distribution of CoW variants within 73 TIA patients 
without intracranial vessel occlusion to evaluate the extent of vari-
ants in a cohort with a similar vascular risk profile.
METHODS
Patient data
In this retrospective data analysis, we used encrypted clinical and 
imaging data from ischemic stroke patients treated with endovas-
cular treatment (EVT) consecutively between January 2012 and 
August 2017 at the Stroke Center of the University Hospital Berne, 
Switzerland. Additionally, a cohort of TIA patients (n = 100) present-
ing between June 2010 and October 2015 at the Stroke Center of 
the University Hospital Zurich, Switzerland, was analyzed. The study 
was performed according to the ethical guidelines of the Canton of 
Berne with approval of the local ethics committee of Berne (KEK: 
231/14) and Zurich (KEK: 2014– 0304). All stroke patients under-
went magnetic resonance imaging (MRI) as primary imaging diag-
nostic, whereas TIA patients received either computed tomography 
(CT) or MRI scan with MRI performed within 24 h after onset. Stroke 
patients were included if acute ischemic stroke due to an MCA- M1- 
occlusion was confirmed by magnetic resonance angiography (MRA), 
diffusion and time- of- flight magnetic resonance angiography (TOF- 
MRA) images were complete with sufficient quality, EVT was at-
tempted, and mRS score at 3 months’ follow- up was available. Stroke 
patients were excluded if prior territorial infarction or additional 
intra- or extracranial vessel occlusions other than extension of the 
M1- occlusion to the internal carotid artery (ICA) could be detected 
on MRI/MRA. In the TIA cohort, patients were excluded if MRI or 
MRA was missing or if the final diagnosis was other than TIA. Patient 
characteristics for stroke patients included demographic informa-
tion (age, sex, independent prior stroke), vascular risk factors (atrial 
fibrillation, diabetes mellitus, arterial hypertension, dyslipidemia, 
current smoking, coronary heart disease, peripheral artery disease, 
prior stroke or TIA), previous medication (antiplatelet therapy, oral 
anticoagulation, statin or antihypertensive therapy), baseline stroke 
admission information (National Institutes of Health Stroke Scale 
[NIHSS] on admission, blood pressure, levels of glucose, glycosylated 
hemoglobin [HbA1c], C- reactive protein [CRP] and international 
normalized ratio [INR]), collateral status, stroke therapy and etiol-
ogy. The percentages of missing values were as follows: age (0%), 
sex (0%), independent prior stroke (10.4%), atrial fibrillation (0.52%), 
diabetes mellitus (0%), arterial hypertension (0%), dyslipidemia (1%), 
current smoking (9.3%), coronary heart disease (0%), peripheral ar-
tery disease (9.3%), prior stroke or TIA (0%), NIHSS on admission 
(0%), 3- month mRS (0%), collateral status (1.6%), stroke etiology ac-
cording to TOAST (Trial of ORG 10172 in Acute Stroke Treatment) 
criteria (0%), onset to groin puncture (2.6%), Thrombolysis In 
Cerebral Infarction (TICI) scale (0%), general anesthesia (3.1%) and 
CoW variants and vascular models (0%).
Circle of Willis assessment and vascular models
The anatomy of the CoW was assessed on TOF- MRA acquired at the 
time of hospital admission for stroke patients or on a follow- up MRI 
within 24 h after symptom onset for TIA patients, respectively. The MRI 
analyses of stroke patients were performed on 1.5T or 3T MRI systems 
from one vendor (Siemens Healthineers, Erlangen, Germany) and for 
TIA patients on 3T MRI systems (Skyra 3T Siemens Healthineers). The 
MRA of stroke patients consisted of 139 slices obtained with a three- 
dimensional (3D) TOF- MRA technique (flip angle 25 degrees, 1 signal 
acquired, slice thickness of 0.5 mm). The MRA of TIA patients com-
prised 200 slices obtained with a 3D TOF- MRA technique (flip angle 
20 degrees, 1 signal acquired, slice thickness of 0.6 mm, and six slaps 
with an overlap of 19% were used). Images were reconstructed and 
analyzed in the axial, coronal or sagittal plane with a maximum inten-
sity projection (MIP) or source- imaging algorithm.
    |  3CIRCLE OF WILLIS VARIANTS IN LVO STROKE
The CoW of stroke patients was assessed by two independent 
raters experienced in neuroradiologic image analysis (LPW and 
NL) after prior training of the readout by a board- certified senior 
neuroradiologist (SWi). In diverging cases, a consensus decision 
was reached after a second imaging analysis, if necessary with the 
assistance of a board- certified senior neuroradiologist (SWi). The 
anterior circulation was considered as differing if the Acom or the 
A1 segment of the anterior cerebral artery (ACA) was hypoplastic 
(<0.8 mm with rounded values, <0.75 mm in absolute values) and 
considered as incomplete if the Acom or one A1 segment was unde-
tectable (aplastic). The posterior circulation was categorized as dif-
fering if one or both Pcom arteries or P1- segments of the posterior 
cerebral artery (PCA) were hypoplastic (<0.8 mm with rounded val-
ues, <0.75 mm in absolute values) [3,4] and classified as incomplete 
if one or both Pcom arteries or PCAs were undetectable (aplastic) 
including cases with a full fetal PCA origin.
After assessing CoW variants, we categorized the CoW of pa-
tients into four vascular models, which we developed according to 
previously reported hypotheses of collateral flow via the CoW [5,6]. 
A schematic visualization of the models and the presumed collat-
eral blood flow dynamics via the CoW is shown in Figure 1a with 
exemplary findings of these models on TOF- MRA images demon-
strated in Figure 1b. Model 1 has a missing or hypoplastic ACA- A1- 
segment ipsilateral to the side of MCA- M1- occlusion with presumed 
collateral flow via the Acom towards the differing A1- segment and 
stroke side thereby likely to provide better collateral flow via lep-
tomeningeal collaterals (LMC) [6,7]. Model 2 describes a missing or 
hypoplastic A1- segment contralateral to stroke and M1- occlusion 
with an expected reverse flow via the Acom to the impaired A1- 
segment possibly leading to a reduction of collateral flow via the 
CoW to the stroke side [7]. Model 3 has a fetal PCA ipsilateral to 
stroke and M1- occlusion side with a presumed collateral blood flow 
via the contralateral Pcom, A1 and Acom. Model 4 corresponds to 
an impaired posterior circulation including a- or hypoplastic Pcom or 
P1- segments ipsilateral to stroke and M1- occlusion with a hypothe-
sized worse clinical outcome due to reduced collateral flow from the 
ipsilateral Pcom to the anterior circulation [7].
Outcome measures
Outcome measures were assessed for the cohort of stroke patients. 
The mRS for 3- month functional impairment after stroke was de-
fined as the primary outcome, whereas mortality defined as death 
occurring within the first 3 months after stroke onset was set as the 
secondary outcome. Favorable outcome was defined as mRS 0– 2, 
unfavorable outcome as mRS 3– 6.
Statistical analysis
For the descriptive analyses, median and interquartile range (IQR) were 
used for continuous variables, whereas categorical variables were 
summarized as counts and percentages of total. The Mann−Whitney 
U test was applied for two- group exploratory comparisons of continu-
ous variables and the Fisher̀ s exact test for comparisons of categorical 
variables. Two different logistic regression models were fitted to model 
favorable outcome defined as 3- month mRS 0– 2 and to estimate the 
strength of association of the four vascular models as well as anterior, 
posterior and all CoW variants on primary outcome with adjustment for 
clinical confounders (age, sex and atrial fibrillation). In the multivariate 
logistic regression analysis, we adjusted for the clinically most relevant 
risk factors, which were significant in the univariate analysis (Table 1) 
and added sex as a common clinical confounder. NIHSS on admission 
was excluded from the logistic regression analysis as it could be influ-
enced by collateral flow and CoW variants, thereby potentially mediat-
ing outcome. Statistical model I included all vascular models, anterior 
and posterior variants, and statistical model II only the vascular models 
simultaneously. An interaction term between the vascular models 1– 4 
was included in each model, but removed if there was no evidence for 
an interaction (i.e., the corresponding p value of the interaction term was 
>0.05). Missing values were considered as missing completely at ran-
dom, therefore a complete case analysis was conducted.
All calculations were performed using STATA 14.1 and R 3.6.0 
(R Core Team, 2019). The study was reported according to the 
STROBE (Strengthening the Reporting of Observational studies in 
Epidemiology) guidelines for observational studies [8].
RESULTS
Stroke and TIA patient data and baseline 
characteristics
We screened 274 acute ischemic stroke patients with MCA- M1- 
occlusion and included 193 into the analysis (Figure 2). A total of 
52 patients were excluded either because of insufficient image 
quality due to excessive head movement or other imaging artifacts 
(n = 32), additional LVO other than extension of the occlusion to 
the ICA (n = 9), prior territorial infarction (n = 7) or missing angi-
ography (n = 4). Furthermore, 29 cases with extra- or intracranial 
ICA- occlusion as a possible confounder for outcome analyses were 
excluded, leading to an overall dataset of 193 stroke patients avail-
able for the analysis of CoW variants. Additionally, we screened 
a cohort of 100 patients who presented with suspicion of a TIA. 
Twenty- seven cases were excluded due to a final diagnosis other 
than TIA or missing MRI data, leading to a set of 73 patients diag-
nosed with a TIA without diffusion restriction or intracranial vessel 
occlusion on follow- up MRI.
As presented in Table 1, the median age of stroke patients was 
73.4 (IQR: 61– 82) years, 61.1% (n = 118) were females and 92.5% 
(n = 160) were independent prior to stroke. Among the vascular risk 
factors, arterial hypertension with 66.3% (n = 128) and dyslipidemia 
with 58.6% (n = 112) were the most frequent. The median NIHSS on 
admission was 12 (IQR: 8– 17). 48.7% (n = 94) of patients underwent 
intravenous thrombolysis, all patients were referred to EVT. Most 
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patients (54.4%, n = 105) were assigned to vascular model 4 (ipsilat-
eral a- or hypoplastic PCA or Pcom) with 49.2% (n = 95) of all CoW 
variants being an ipsilateral a- or hypoplastic Pcom (see Table 1). In 
the anterior circulation, an a- or hypoplastic A1- segment (vascular 
model 1) was observed in 7.8% (n = 15) on the ipsilateral side and in 
6.2% (n = 12) on the contralateral side of the M1- occlusion (Table 1).
Distribution of CoW variants in stroke and 
TIA patients
Some 82.4% (n = 159) of ischemic stroke patients with MCA- M1- 
occlusion showed a differing or incomplete CoW including a- or 
hypoplastic vessels of the anterior (ACA- A1 or Acom) or posterior 
circulation (PCA- P1 or Pcom) as shown in Table 2. From these, 39.9% 
(n = 77) had variants of the anterior circulation and 77.2% (n = 149) 
a differing or incomplete posterior circulation (Table 2). Among an-
terior CoW variants, a differing Acom was the most frequent find-
ing (n = 59, 30.6% of all CoW variants), whereas a hypoplastic P1 or 
Pcom was most often observed in posterior CoW variants (n = 114, 
59%) (see Table 2).
In TIA patients without intracranial vessel occlusion, we found 
a total amount of 72.6% (n = 53) of CoW variants as also presented 
in Table 2 (vs. 82.4% [n = 159] in stroke patients, p = 0.088). From 
these, 45.2% (n = 33) were anterior circulation variants (vs. 39.9% 
[n = 77] in stroke patients, p = 0.486). Posterior circulation variants 
F I G U R E  1  Scheme of vascular models 
of circle of Willis (CoW) variants (a) and 
visualization in time- of- flight magnetic 
resonance angiography (TOF- MRA). 
(b) Axial magnetic resonance images of 
acute ischemic stroke patients performed 
on admission showing the CoW in 
3D- multi- slab TOF- angiography in the 
maximum intensity projection (MIP). 
CoW variant indicated with a white 
arrow on each image. 1: Hypoplastic 
A1- segment ipsilateral to M1- occlusion 
on the right side; 2: aplastic A1- segment 
contralateral to M1- occlusion on the right 
side; 3: full fetal PCA ipsilateral to M1- 
occlusion on the left side; 4: hypoplastic 
Pcom ipsilateral to M1- occlusion on 
the right side. Abbreviations: Acom, 
anterior communicating artery; ICA, 
internal carotid artery; MCA, middle 
cerebral artery; PCA, posterior cerebral 
artery; Pcom, posterior communicating 
artery
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TA B L E  1  Baseline characteristics of stroke patients





(n = 89) p Alive (n = 162) Dead (n = 31) p
Demographic factors
Age, median (IQR) 73.4 (61– 82) 68.7 (57– 77) 79.7 (68– 86) <0.001 70.9 (60– 79) 83.4 (79– 88) <0.001
Female sex, n (%) 118 (61.1) 62 (59.6) 56 (62.9) 0.66 100 (61.7) 18 (58.1) 0.69
Independent prior stroke, 
n (%)
160 (92.5) 93 (96.9) 67 (87) <0.05 139 (95.2) 21 (77.8) <0.01
Vascular risk factors, n (%)
Atrial fibrillation 84 (43.8) 37 (35.9) 47 (52.8) <0.05 66 (41.0) 18 (58.1) 0.11
Diabetes mellitus 33 (17.1) 11 (10.6) 22 (24.7) <0.05 26 (16.1) 7 (22.6) 0.43
Arterial hypertension 128 (66.3) 58 (55.8) 70 (78.7) <0.01 106 (65.4) 22 (71) 0.68
Dyslipidemia 112 (58.6) 64 (61.5) 48 (55.2) 0.38 100 (62.1) 12 (40) <0.05
Current smoking 40 (22.9) 27 (27.6) 13 (16.9) 0.11 37 (24.8) 3 (11.5) 0.20
Coronary heart disease 30 (15.5) 17 (16.4) 13 (14.6) 0.84 24 (14.8) 6 (19.4) 0.59
Peripheral artery disease 6 (3.4) 1 (1) 5 (6.3) 0.09 4 (2.7) 2 (7.4) 0.23
Prior stroke or TIA 27 (13.9) 15 (14.2) 12 (13.5) 1.00 22 (13.6) 5 (16.1) 0.78
Previous medication, n (%)
Antiplatelets 61 (31.6) 27 (26.0) 34 (38.2) 0.09 48 (29.6) 13 (41.9) 0.21
Oral anticoagulants 20 (10.4) 10 (9.6) 10 (11.2) 0.81 15 (9.3) 5 (16.1) 0.33
Statins 41 (21.4) 21 (20.4) 20 (22.5) 0.73 36 (22.4) 5 (16.1) 0.63
Antihypertensives 111 (57.5) 52 (50.0) 59 (66.3) <0.05 91 (56.2) 20 (64.5) 0.43
Clinical parameters, median (IQR)
NIHSS on admission 12 (8– 17) 11 (8– 15) 15 (10– 19) 0.001 12 (8– 16) 16 (8– 20) <0.05
Systolic blood pressure 152 (133– 168) 146 (131– 161) 158 (136– 173) <0.05 150 (133– 167) 160 (144– 175) 0.1
Diastolic blood pressure 82 (70– 95) 81 (70– 92) 82 (69– 96) 0.76 81 (70– 93) 85 (75– 100) 0.25
Onset to groin puncture 
in min
217 (163– 391) 210 (160– 316) 240 (165– 447) 0.34 212 (163– 364) 245 (159– 476) 0.57
TICI score after EVTc , n (%)
0 10 (5.2) 2 (1.9) 8 (9) <0.05 7 (4.3) 3 (9.7) 0.076
1 8 (4.2) 2 (1.9) 6 (6.7) 4 (2.5) 4 (12.9)
2a 24 (12.4) 13 (12.5) 11 (12.4) 21 (13) 3 (9.7)
2b 68 (35.2) 34 (32.7) 34 (38.2) 58 (35.8) 10 (32.3)
3 83 (43) 53 (51) 30 (33.7) 72 (44.4) 11 (35.5)
General anesthesia 88 (46.6) 45 (45.5) 41 (46.6) 0.88 71 (45.5) 15 (48.4) 0.85
LMC status, n (%)
Weak or no (0) 20 (10.4) 9 (8.7) 11 (12.4) 0.43 18 (11.1) 2 (6.5) 0.71
Moderate (1) 68 (35.2) 35 (33.7) 33 (37.1) 58 (35.8) 10 (32.3)
Good (2) 102 (52.9) 60 (57.7) 42 (47.2) 84 (51.9) 18 (58.1)
CoW incomplete/differing, n (%) 159 (82.4) 85 (81.7) 74 (83.2) 0.85 130 (80.3) 29 (93.6) 0.119
Vascular models, n (%)
1 (ipsilateral a- /hypoplastic 
A1)
15 (7.8) 9 (8.7) 6 (6.7) 0.79 13 (8) 2 (6.5) 1.00
2 (contralateral a- /
hypoplastic A1)
12 (6.2) 7 (6.7) 5 (5.6) 1.00 10 (6.2) 2 (6.5) 1.00
3a (ipsilateral full fetal PCA) 11 (5.7) 8 (7.7) 3 (3.4) 0.23 9 (5.6) 2 (6.5) 0.69
(Continues)
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were detected less frequently in TIA patients (58.9% [n = 43] vs. 
77.2% [n = 149] in stroke patients, p = 0.004). A detailed list of the 
distribution of the different CoW variants of both patient cohorts 
can be found in Table 2. The median age of TIA patients was 73 years 
(IQR: 64– 78 years, compared to stroke patients, p = 0.582). There 
were more women in the stroke group (61.1% [n = 118] vs. 39.7% 
[n = 29] in TIA patients, p = 0.002). When adjusting stroke and TIA 
patients for sex, we found no evidence for a differing amount of all 
CoW variants or anterior variants, while the difference in posterior 
variants between stroke and TIA patients remained (p = 0.0076).
Association of CoW variants with clinical parameters 
in stroke and TIA patients
When comparing stroke patients with a complete CoW to patients 
with any CoW variant or only anterior or posterior variants, the median 
age of all groups with CoW variants was higher compared to the group 
without variants (normal CoW: 68.7 [IQR: 56– 80] years; all CoW vari-
ants: 74.5 [IQR: 62– 82] years, p = 0.22). Within the group of posterior 
variants, there was evidence for a higher median age of stroke patients 
with variants (74.7 [IQR: 64– 82] years vs. 67.7 [IQR: 55– 79] years) (see 
Table S1). In TIA patients, we found a median age of 74 years (IQR: 
65– 80) in patients with any CoW variant compared to 69 years (IQR: 
55– 77) in patients with a normal CoW (p = 0.19) as shown in Table 
S1). Regarding stroke severity, there was no evidence for a differing 
NIHSS on admission between groups with different CoW variants. 
Furthermore, there was no evidence for a difference between the 
groups with and without variants for neither the LMC status assessed 
during the initial digital subtraction angiography (DSA), nor success of 
recanalization assessed by the TICI scale (Table S1).
Outcome analysis of CoW variants in stroke patients
In patients with any CoW variant there was a trend towards a higher 
mortality compared to patients with an intact CoW (18.2% vs. 5.9%, 
p = 0.08), in particular in patients with posterior circulation variants 
(p = 0.058) (see Table S1). When stratifying the group of all CoW var-
iants (n = 159) within the stroke cohort for outcome and mortality, 
respectively, there was a tendency towards more incomplete CoW 





(n = 89) p Alive (n = 162) Dead (n = 31) p
3b (two- sided full fetal PCA) 2 (1) 2 (1.9) 0 (0) 0.50 2 (1.2) 0 (0) 1.00
4 (ipsilateral a- /hypoplastic 
PCA/Pcom)
105 (54.4) 60 (57.7) 45 (50.6) 0.39 86 (53.1) 19 (61.3) 0.44
4a (ipsilateral hypoplastic 
PCA/Pcom)
73 (37.8) 40 (38.5) 33 (37.1) 0.88 61 (37.7) 12 (38.7) 1.00
4b (ipsilateral aplastic PCA/
Pcom)
32 (16.6) 20 (19.2) 12 (13.5) 0.33 25 (15.4) 7 (22.6) 0.31
4c (two- sided a- /hypoplastic 
PCA/Pcom)
89 (46.1) 48 (46.2) 41 (46.1) 1.00 73 (45.1) 16 (51.6) 0.56
4d (ipsilateral a- /hypoplastic 
Pcom)
95 (49.2) 55 (52.9) 40 (44.9) 0.31 78 (48.2) 17 (54.8) 0.56
Abbreviations: CoW, circle of Willis; DSA, digital subtraction angiography; EVT, endovascular treatment; IQR, interquartile range; LMC, 
leptomeningeal collateral; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; Pcom, 
communicating posterior artery; TIA, transient ischemic attack; TICI, Thrombolysis In Cerebral Infarction. Bold values mark statistically significant 
values.
a(mRS ≤ 2).
b(mRS ≥ 3– 6).
cLMC status assessed during initial DSA; TICI scale: 0, no perfusion; 1, penetration with minimal perfusion; 2a, partial perfusion <2/3 of the entire 
vascular territory; 2b, complete filling of the expected vascular territory, but with a perceptibly slower filling rate; 3, complete perfusion.
TA B L E  1  (Continued)
F I G U R E  2  Flow chart of study population. Abbreviations: ICA, 
internal carotid artery; MRA, magnetic resonance angiography
Ischemic stroke patients with
MCA-M1-occlusion screened
between 2012-17 in Berne with
MR perfusion data (n=274) 
MRA data (n=222) 
Final data set (n=193) 
Multiple occlusion sites (n=9) 
Insufficient image quality (n=32) 
Prior territorial infarction (n=7) 
Missing angiography (n=4) 
Additional ICA occlusion/stenosis
(n=29) 
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among patients dying within 3 months after stroke onset (93.6% 
[n = 29] vs. 80.3% [n = 130], p = 0.119) (see Table 1). However, there 
was no evidence for a differing outcome after 3 months. An illustra-
tion of the distribution of 3- month mRS stratified for patients with a 
complete CoW, all, anterior or posterior variants and the four vascu-
lar models is presented in Figure 3.
Since we assumed that an imbalance of clinical variables such as 
slightly older age in patients with CoW variants might affect our out-
come comparison, we conducted a logistic regression analysis in order to 
evaluate the association of CoW variants on favorable clinical outcome 
adjusted for clinical confounders. When analyzing the four vascular 
models and also adding anterior and posterior variants as exploratory 
variables (statistical model I), we did not find enough evidence to claim 
that either one of the vascular models or the variants had a reliable ef-
fect on outcome (the estimated change in odds ratio and 95% confidence 
intervals are shown in Figure 4). We additionally performed the analysis 
including only the four vascular models (statistical model II) and again 
there was no evidence for an association of the included variables with 
favorable outcome. In both statistical models, there was no evidence for 
an interaction between the vascular models 1– 4.
DISCUSSION
CoW variants are frequent and their presence and shape have been 
associated with ischemic stroke previously [4,6,9]. However, it is 
TA B L E  2  Distribution of circle of Willis variants in stroke and transient ischemic attack patients
Stroke cohort
All




Incomplete/differinga  159 (82.4) Incomplete/differinga  53 (72.6)
Anterior CoW, n (%)
A1 or Acom incomplete/differing 77 (39.9) A1 or Acom incomplete/differing 33 (45.2)
A1 or Acom hypoplastic 65 (33.7) A1 or Acom hypoplastic 30 (41.1)
A1 or Acom aplastic 15 (7.8) A1 or Acom aplastic 3 (4.1)
A1- asymmetry 26 (13.5) A1- asymmetry 10 (13.7)
A1- asymmetry (ipsilateral) 15 (7.8) A1- asymmetry (ipsilateral) NA
A1 hypoplastic (ipsilateral) 9 (4.7) A1 hypoplastic 8 (11)
A1 aplastic (ipsilateral) 6 (3.1) A1 aplastic 2 (2.7)
Acom differing 59 (30.6) Acom differing 23 (31.5)
Acom hypoplastic 54 (28.0) Acom hypoplastic 22 (30.1)
Acom aplastic 5 (2.6) Acom aplastic 1 (1.4)
Azygos variant 2 (1) Azygos variant 1 (1.4)
Posterior CoW, n (%)
P1 or Pcom incomplete/differing 149 (77.2) P1 or Pcom incomplete/differing 43 (58.9)
P1 or Pcom incomplete/differing (ipsilateral) 105 (54.4) P1 or Pcom incomplete/differing (ipsilateral) NA
P1 or Pcom hypoplastic 114 (59.1) P1 or Pcom hypoplastic 32 (43.8)
P1 or Pcom hypoplastic (ipsilateral) 74 (38.3) P1 or Pcom hypoplastic (ipsilateral) NA
P1 or Pcom aplastic 55 (28.5) P1 or Pcom aplastic 12 (16.4)
P1 or Pcom aplastic (ipsilateral) 31 (16.1) P1 or Pcom aplastic (ipsilateral) n.a.
P1 or Pcom one- sided differing 60 (31.1) P1 or Pcom one- sided differing 29 (39.7)
P1 or Pcom two- sided differing 89 (46.1) P1 or Pcom two- sided differing 14 (19.2)
Pcom differing (ipsilateral) 95 (49.2) Pcom differing 39 (53.4)
Pcom hypoplastic (ipsilateral) 64 (33.2) Pcom hypoplastic 28 (38.4)
Pcom aplastic (ipsilateral) 31 (16.1) Pcom aplastic 12 (16.4)
Full fetal PCA 21 (10.9) Full fetal PCA 4 (5.5)
Full fetal PCA (ipsilateral) 11 (5.7) Full fetal PCA (ipsilateral) NA
Partial fetal PCA 54 (28.0) Partial fetal PCA 16 (21.9)
Partial fetal PCA (ipsilateral) 38 (19.7) Partial fetal PCA (ipsilateral) NA
Abbreviations: Acom, anterior communicating artery; CoW, circle of Willis; NA, not applicable; PCA, posterior cerebral artery; Pcom, posterior 
communicating artery; TIA, transient ischemic attack.
aIncluding all CoW variants.
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unknown if CoW variants affect outcome in MCA- M1- occlusion 
stroke after EVT.
Our aim was to assess the frequency and distribution of CoW 
variants in a MCA- M1- occlusion stroke and TIA cohort without in-
tracranial vessel occlusion and to investigate the potential impact of 
CoW variants on stroke outcome. Our hypothesis was that an acute 
intracranial vessel occlusion might be partially compensated by col-
lateral flow via the CoW in the setting of a complete CoW, but less 
tolerated in an incomplete CoW. However, some conditions such 
as a missing A1- segment ipsilateral to an acute MCA- M1- occlusion 
(model 1) could be beneficial by providing additional collateral flow 
via a well- established Acom and LMC towards the missing A1- 
segment and stroke side [6,7]. This led to the development of four 
vascular models of presumed flow compensation in cases of MCA- 
M1- occlusion stroke (Figure 1) according to previously described 
flow dynamics in patients with LVO [5– 7]. We found that a high 
(82.4%) proportion of patients with MCA- M1- occlusion stroke had 
an incomplete or hypoplastic CoW affecting predominantly the pos-
terior circulation (77.2%), which is in line with previous data [10].
Despite a trend towards a higher mortality in patients with any 
CoW variant in our study, the presence of any type of CoW vari-
ant was not independently associated with 3- month functional out-
come after adjusting for potential clinical confounders, particularly 
age. Furthermore, none of the vascular models of presumed collat-
eral flow in different conditions of missing CoW segments could be 
confirmed in our outcome analysis. In line with our results, a recent 
study analyzing ipsilateral CoW variants in patients with MCA- or 
ICA- occlusion found no evidence for an effect of these CoW vari-
ants on clinical outcome [11]. However, in that analysis, contralateral 
CoW variants as well as Acom variants were not included [11]. In 
line with our results, a study by Shaban et al. [12] could not find an 
association between the presence of a fetal PCA and stroke severity 
or early outcome in a heterogenic cohort including different stroke 
etiologies.
Similar to other studies, we found that older age was associated 
with a higher frequency of CoW variants in patients with stroke 
[3,9,11,12] which is likely to affect outcome analyses, if not adjusted. 
Results from a twin study by Forgo et al. [1] suggest that environ-
mental rather than genetic effects determine CoW variants after 
demonstrating a high rate of discordance of CoW variants in mono-
zygote twins. Another anatomical study demonstrated that some hy-
poplastic arteries have inward vascular remodeling consistent with 
atherosclerotic arterial occlusion [13] which might explain to some 
extent the higher frequency of CoW variants in older individuals.
Except for fewer posterior variants in the TIA cohort, we found 
no evidence for a difference in frequency and distribution of CoW 
variants in TIA compared to stroke patients. The difference in poste-
rior variants remained after adjusting both cohorts for sex. Although 
some imbalance in the rather small sample size of TIA patients might 
contribute to this finding, we cannot rule out that certain CoW vari-
ants, such as posterior variants, render patients more susceptible to 
MCA- M1- occlusion stroke.
The strengths of our study are the clinically well- characterized 
patient cohort with a homogenous intracranial vessel status, includ-
ing only patients with stroke due to MCA- M1- occlusion and no addi-
tional extra- or intracranial vessel stenosis or occlusion. Furthermore, 
the CoW was assessed by two blinded and independent physicians 
with neuroradiological expertise trained and supervised by a board- 
certified neuroradiologist. Additionally, we analyzed data from a TIA 
cohort in order to assess the distribution of CoW variants in a similar 
vascular patient cohort without any intracranial vessel occlusion.
Limitations of the study are the small sample size of subgroups 
among the different CoW variants and classification into vascular 
models and subgroups of variants, which affect the power of our 
F I G U R E  3  Distribution of 3- month 
modified Rankin scale (mRS) among circle 
of Willis (CoW) variants. No V = no CoW 
variants, all V = all CoW variants, ant. 
V = all anterior circulation variants, post. 
V = all posterior circulation variants, 
M1 = model 1 (ipsilateral a- or hypoplastic 
A1), M2 = model 2 (contralateral 
a- or hypoplastic A1), M3 = model 3 
(ipsilateral fetal posterior cerebral artery), 
M4 = model 4 (ipsilateral a- or hypoplastic 
P1 or posterior communicating artery)
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study. Furthermore, MRA may underestimate the size of vessels 
within the CoW compared to DSA as imaging gold standard [4]. Due 
to the small size of CoW segments, the true number of patients with 
a complete CoW might be higher. Nevertheless, the amount of dif-
ferent CoW variants we found was in accordance with other studies 
using different methods [9,10]. Furthermore, the restriction to an 
LVO stroke cohort might have influenced or overlapped the effect 
of CoW variants on outcome.
In conclusion, our study shows that CoW variants are a frequent 
finding in ischemic stroke patients with MCA- M1- occlusion. There 
was no evidence for an association of CoW variants with 3- month 
functional disability. However, the level of evidence indicates a trend 
towards a higher mortality in patients with any type of CoW variant 
and a higher frequency of incomplete CoW among patients dying 
within 3 months after stroke onset represent valuable hints to val-
idate these results in future studies. In addition, the role of CoW 
variants for intracranial vessel occlusions other than MCA- M1 and 
the association of the LMC status among the different subgroups of 
CoW variants with outcome could be addressed in further studies 
with larger patient cohorts.
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